Boston Trust Walden’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $382K | Hold |
5,471
| – | – | ﹤0.01% | 334 |
|
2025
Q1 | $402K | Hold |
5,471
| – | – | ﹤0.01% | 325 |
|
2024
Q4 | $358K | Sell |
5,471
-695
| -11% | -$45.5K | ﹤0.01% | 339 |
|
2024
Q3 | $480K | Buy |
6,166
+711
| +13% | +$55.4K | ﹤0.01% | 320 |
|
2024
Q2 | $425K | Buy |
5,455
+55
| +1% | +$4.29K | ﹤0.01% | 328 |
|
2024
Q1 | $366K | Hold |
5,400
| – | – | ﹤0.01% | 335 |
|
2023
Q4 | $364K | Hold |
5,400
| – | – | ﹤0.01% | 330 |
|
2023
Q3 | $366K | Hold |
5,400
| – | – | ﹤0.01% | 319 |
|
2023
Q2 | $386K | Hold |
5,400
| – | – | ﹤0.01% | 322 |
|
2023
Q1 | $375K | Hold |
5,400
| – | – | ﹤0.01% | 325 |
|
2022
Q4 | $366K | Hold |
5,400
| – | – | ﹤0.01% | 326 |
|
2022
Q3 | $296K | Hold |
5,400
| – | – | ﹤0.01% | 327 |
|
2022
Q2 | $357K | Hold |
5,400
| – | – | ﹤0.01% | 326 |
|
2022
Q1 | $358K | Hold |
5,400
| – | – | ﹤0.01% | 335 |
|
2021
Q4 | $315K | Hold |
5,400
| – | – | ﹤0.01% | 356 |
|
2021
Q3 | $324K | Hold |
5,400
| – | – | ﹤0.01% | 347 |
|
2021
Q2 | $323K | Hold |
5,400
| – | – | ﹤0.01% | 351 |
|
2021
Q1 | $268K | Hold |
5,400
| – | – | ﹤0.01% | 350 |
|
2020
Q4 | $270K | Hold |
5,400
| – | – | ﹤0.01% | 353 |
|
2020
Q3 | $296K | Hold |
5,400
| – | – | ﹤0.01% | 340 |
|
2020
Q2 | $286K | Hold |
5,400
| – | – | ﹤0.01% | 338 |
|
2020
Q1 | $241K | Hold |
5,400
| – | – | ﹤0.01% | 334 |
|
2019
Q4 | $269K | Hold |
5,400
| – | – | ﹤0.01% | 356 |
|
2019
Q3 | $241K | Hold |
5,400
| – | – | ﹤0.01% | 363 |
|
2019
Q2 | $223K | Hold |
5,400
| – | – | ﹤0.01% | 368 |
|
2019
Q1 | $218K | Hold |
5,400
| – | – | ﹤0.01% | 370 |
|
2018
Q4 | $205K | Hold |
5,400
| – | – | ﹤0.01% | 367 |
|
2018
Q3 | $214K | Buy |
+5,400
| New | +$214K | ﹤0.01% | 372 |
|
2014
Q3 | – | Sell |
-5,400
| Closed | -$201K | – | 336 |
|
2014
Q2 | $201K | Buy |
+5,400
| New | +$201K | ﹤0.01% | 335 |
|